These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9557230

  • 1. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA.
    Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ.
    Dermatology; 1998; 196(1):69-70. PubMed ID: 9557230
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M.
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel 23S rRNA mutation in Propionibacterium acnes confers resistance to 14-membered macrolides.
    Nakase K, Nakaminami H, Takenaka Y, Hayashi N, Kawashima M, Noguchi N.
    J Glob Antimicrob Resist; 2016 Sep; 6():160-161. PubMed ID: 27530860
    [No Abstract] [Full Text] [Related]

  • 8. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S.
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [Abstract] [Full Text] [Related]

  • 9. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes.
    Crawford WW, Crawford IP, Stoughton RB, Cornell RC.
    J Invest Dermatol; 1979 Apr; 72(4):187-90. PubMed ID: 429800
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M, Wasik B, Becker A, Höffler U.
    Dermatology; 2002 Apr; 205(3):260-4. PubMed ID: 12399674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA, Cove JH, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [Abstract] [Full Text] [Related]

  • 16. [In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin].
    Lucca L, Vittadini G.
    G Ital Chemioter; 1979 Jul; 26(1-2):203-6. PubMed ID: 554810
    [No Abstract] [Full Text] [Related]

  • 17. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM.
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.